Nita Mercer
Nurse Practitioner · New Bern, NCNPI 1346281466
Payments from drug & device makers
Across 95 payments — averaging $18.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$398
- Novo Nordisk$304
- Takeda Pharmaceuticals U.S.A., Inc.$142
- Myriad Women's Health, Inc.$141
- Lilly USA, LLC$80
- Axsome Therapeutics, Inc.$72
- plus $600 from 17 others
What the payments were for
- Food & beverage$1,737100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 25 | $398 |
| Novo Nordisk | 18 | $304 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $142 |
| Myriad Women's Health, Inc. | 1 | $141 |
| Lilly USA, LLC | 5 | $80 |
| Axsome Therapeutics, Inc. | 5 | $72 |
| Abbott | 3 | $71 |
| Bayer | 4 | $61 |
| Pfizer | 4 | $57 |
| Lundbeck LLC | 2 | $53 |
| Organon | 2 | $46 |
| Boston Scientific | 2 | $39 |
| Astellas Pharma US Inc | 2 | $36 |
| Biohaven Pharmaceuticals, Inc. | 2 | $34 |
| Radius Health, Inc. | 2 | $32 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Amgen | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Mayne Pharma Commercial LLC | 1 | $21 |
| Medtronic | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Evofem Biosciences, Inc. | 1 | $17 |
| Biogen | 1 | $17 |
How this compares
$1,737 in reported general payments places this provider in the 80th percentile of 4,393 nurse practitioner providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 25 | $1,555 |
| Estradiol | 20 | $1,475 |
| ValacyclovirValacyclovir Hcl | 12 | $1,019 |
| Nystatin | 23 | $500 |
| Metronidazole | 23 | $264 |
| Paroxetine Hcl | 12 | $190 |
| Spironolactone | 16 | $150 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 15 | $99 |
| Fluconazole | 16 | $57 |
| Misoprostol | 11 | $15 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in New Bern
- Vinetta McCannNew Bern$16K
- Sandrivette JohnsonRaleigh$573K
- Skyler RogersPinehurst$174K
- Jamie DinerDurham$170K
- Ayeshia WrightMocksville$145K
- Deborah AllenDurham$112K
- Jeanann VawterGastonia$97K
- Terra KampJacksonville$72K
- Mary DilorenzoCharlotte$71K
- Olivia OgburnWinston Salem$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.